Affinage

GIMAP5

GTPase IMAP family member 5 · UniProt Q96F15

Length
307 aa
Mass
34.8 kDa
Annotated
2026-04-28
36 papers in source corpus 21 papers cited in narrative 21 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GIMAP5 is a lysosome-associated GTPase that maintains lymphocyte survival, hematopoietic progenitor integrity, and hepatic sinusoidal endothelial cell (LSEC) identity through regulation of ceramide metabolism, calcium homeostasis, and GSK3β signaling. GIMAP5 restrains ceramide accumulation by interacting with CK2 and attenuating CK2-driven ceramide synthase activation, while its absence causes long-chain ceramide overaccumulation, cell senescence, and apoptosis (PMID:38172257); it also promotes mitochondrial calcium buffering via a microtubule-dependent mechanism (PMID:23098229) and prevents ER stress–mediated apoptosis through the CHOP pathway (PMID:19424493). Following TCR engagement, GIMAP5 is required for GSK3β inactivation, enabling c-Myc induction and NFATc1 nuclear import to drive CD4⁺ T cell proliferation, and loss-of-function mutations in humans and mice cause T cell lymphopenia, colitis, and portal hypertension from LSEC capillarization upstream of GATA4 (PMID:29382851, PMID:15328390, PMID:33956074). GIMAP5 protein stability depends on a lysosomal complex with MFSD1 and GLMP, whose disruption phenocopies GIMAP5 deficiency (PMID:38055739).

Mechanistic history

Synthesis pass · year-by-year structured walk · 12 steps
  1. 2003 Medium

    Establishing that GIMAP5 is an antiapoptotic protein that localizes to the centrosomal/ER region and antagonizes CaMKII-dependent caspase-3 activation answered the initial question of whether this GTPase family member has a survival function.

    Evidence Domain-deletion constructs, caspase-3 activity assays, and confocal microscopy in Jurkat T cells

    PMID:12925764

    Open questions at the time
    • Centrosomal/ER localization was later revised to lysosomes by more definitive methods
    • Antiapoptotic mechanism via CaMKII not further developed in subsequent studies
    • Endogenous protein not examined in primary cells
  2. 2004 High

    Transgenic rescue proved that GIMAP5 loss-of-function is the direct cause of T cell lymphopenia in BB rats, establishing the gene as essential for T cell survival in vivo.

    Evidence 150-kb PAC transgenic rescue of Ian5 expression and T cell numbers in F344.lyp/lyp rats

    PMID:15328390

    Open questions at the time
    • Molecular mechanism by which GIMAP5 prevents T cell death was unknown
    • Whether the phenotype extends beyond T cells was not addressed
  3. 2008 High

    Conditional knockout in mice revealed that GIMAP5 controls intrathymic maturation and peripheral T cell survival cell-intrinsically, while also affecting NK/NKT cells cell-extrinsically, broadening its role beyond peripheral T cell survival.

    Evidence Gimap5 conditional KO mice; bone marrow transfer experiments; flow cytometry

    PMID:18796632

    Open questions at the time
    • Cell-extrinsic mechanism affecting NK/NKT cells not identified
    • Nature of the liver pathology was unexplained
  4. 2009 Medium

    Identification of ER stress and CHOP-mediated apoptosis as a downstream consequence of GIMAP5 loss provided the first intracellular pathway explaining T cell death, and CHOP knockdown partially rescued survival.

    Evidence ER stress marker analysis and siRNA knockdown of CHOP in GIMAP5-deficient rat T cells

    PMID:19424493

    Open questions at the time
    • How GIMAP5 prevents ER stress was not determined
    • Calcium entry defect (PMID:19007993) and ER stress were not mechanistically linked
  5. 2010 High

    Definitive localization of endogenous GIMAP5 to lysosomes/multivesicular bodies across rat, mouse, and human cells resolved prior conflicting localization data and placed its function at the lysosomal membrane.

    Evidence Confocal co-localization with lysosomal markers, subcellular fractionation, and electron microscopy in three species

    PMID:21487483

    Open questions at the time
    • Whether lysosomal localization is required for antiapoptotic activity was not tested
    • GTPase cycle regulation at the lysosome unknown
  6. 2010 High

    ENU mutagenesis of the GTPase P-loop showed that GTP-binding integrity is required for lymphocyte quiescence maintenance and antigen-receptor-driven proliferation, operating via a noncanonical pathway independent of NF-κB, MAPK, and Akt.

    Evidence ENU point mutant; fetal liver chimeras; proliferation assays; signaling pathway Western blots

    PMID:20190135

    Open questions at the time
    • Identity of the noncanonical pathway was unknown
    • Whether GTP hydrolysis or GTP binding is the critical activity was not resolved
  7. 2011 High

    Discovery that GIMAP5 deficiency destabilizes Mcl-1 by disrupting the Mcl-1/HSC70 interaction and that GIMAP5 binds Bcl-2 extended its prosurvival function to hematopoietic stem/progenitor cells and connected it to the Bcl-2 family.

    Evidence Co-immunoprecipitation of Mcl-1/HSC70 in Gimap5 KO mice; Bcl-2 binding assay; HSC flow cytometry

    PMID:21502331

    Open questions at the time
    • Whether GIMAP5 directly stabilizes the Mcl-1/HSC70 complex or acts indirectly was not resolved
    • Bcl-2 interaction not mapped to specific domains
  8. 2013 Medium

    Demonstration that GIMAP5 promotes mitochondrial calcium sequestration in a microtubule-dependent manner linked its lysosomal residence to mitochondrial calcium buffering and explained the calcium entry defect observed earlier.

    Evidence Mitochondria-targeted aequorin Ca²⁺ imaging in primary rat T cells and HEK-293 overexpression; nocodazole disruption of microtubules

    PMID:23098229

    Open questions at the time
    • Direct physical interaction between GIMAP5 and tubulin was not demonstrated
    • Mechanism linking lysosomal GIMAP5 to mitochondrial Ca²⁺ uptake remains unclear
  9. 2018 High

    Identification of GSK3β as a critical downstream target of GIMAP5 resolved the noncanonical signaling pathway: GIMAP5 enables GSK3β inactivation upon TCR stimulation, permitting c-Myc induction and NFATc1 nuclear import; pharmacological or genetic GSK3β inhibition rescued GIMAP5-deficient T cell proliferation in mouse and human cells.

    Evidence GSK3β phosphorylation/localization analysis; conditional GSK3β KO crosses; pharmacological rescue; human patient T cell assay

    PMID:29382851

    Open questions at the time
    • Direct physical interaction between GIMAP5 and GSK3β not shown
    • How lysosomal GIMAP5 influences cytoplasmic/nuclear GSK3β activity is unknown
  10. 2021 High

    Extending GIMAP5 function beyond lymphocytes, its loss in hepatic sinusoidal endothelial cells caused capillarization and portal hypertension in both humans and mice, placing GIMAP5 upstream of GATA4 in LSEC specification.

    Evidence Human homozygous mutations in 4 families; endothelial-specific Gimap5 KO mice; scRNA-seq; portal pressure measurement

    PMID:33956074

    Open questions at the time
    • Whether GIMAP5 directly regulates GATA4 transcription or protein stability is unknown
    • Whether the ceramide or GSK3β mechanisms operate in LSECs was not tested
  11. 2023 High

    Discovery of the MFSD1–GLMP–GIMAP5 lysosomal complex established that GIMAP5 protein stability depends on physical interaction with these lysosomal membrane partners, explaining why MFSD1/GLMP deficiency phenocopies GIMAP5 loss.

    Evidence Mass spectrometry of MFSD1 interactors; ENU alleles and germline KO of Mfsd1, Glmp, Gimap5; co-IP; Western blot for GIMAP5 levels

    PMID:38055739

    Open questions at the time
    • Stoichiometry and structural basis of the trimeric complex unknown
    • Whether MFSD1 transporter activity is functionally linked to GIMAP5 signaling is untested
  12. 2024 High

    Identification of the CK2–ceramide synthase axis as a direct GIMAP5-regulated pathway provided a unifying lipid-based mechanism: GIMAP5 interacts with CK2 to restrain ceramide synthase activation, and its loss causes pathological ceramide accumulation, senescence, and death, rescuable by CK2 or ceramide synthase inhibitors.

    Evidence Co-IP of GIMAP5 with CK2; lipidomics; pharmacological inhibition of CK2 and ceramide synthase; human genetic disease identification

    PMID:38172257

    Open questions at the time
    • Whether ceramide accumulation accounts for all downstream defects (ER stress, calcium, GSK3β dysregulation) is unknown
    • Structural basis of GIMAP5–CK2 interaction not determined
    • Whether CK2 inhibition rescues LSEC phenotype is untested

Open questions

Synthesis pass · forward-looking unresolved questions
  • A central unresolved question is how the multiple downstream pathways controlled by GIMAP5 (ceramide metabolism, GSK3β inactivation, calcium buffering, ER stress, Mcl-1 stabilization) are hierarchically organized—specifically whether ceramide restriction is the proximal event from which other defects flow.
  • No integrated epistasis experiment ordering ceramide, GSK3β, calcium, and ER stress pathways
  • GTPase cycle regulation and GTP hydrolysis rate of GIMAP5 remain uncharacterized
  • No structural model of GIMAP5 or its complexes exists

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 2 GO:0003924 GTPase activity 1
Localization
GO:0005764 lysosome 3 GO:0005783 endoplasmic reticulum 2
Pathway
R-HSA-162582 Signal Transduction 2 R-HSA-168256 Immune System 2 R-HSA-1430728 Metabolism 1
Partners
BCL2CSNK2A1GLMPGSK3BM6PRMCL1MFSD1
Complex memberships
MFSD1–GLMP–GIMAP5 lysosomal complex

Evidence

Reading pass · 21 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 GIMAP5 (Irod/Ian5) localizes to the centrosomal/Golgi/endoplasmic reticulum compartment and protects Jurkat T-cells against okadaic acid- and gamma-radiation-induced apoptosis by antagonizing a calmodulin-dependent protein kinase II (CaMKII)-dependent step upstream of caspase-3 activation. Deletion of the C-terminal membrane binding domain or N-terminal GTP-binding domain did not affect antiapoptotic function; the middle coiled-coil domain was responsible for centrosomal anchoring and apoptosis resistance. Subcellular fractionation, confocal microscopy, domain deletion mutants, caspase-3 activity assay, CaMKII inhibitor studies in Jurkat T-cells Molecular biology of the cell Medium 12925764
2004 A single point mutation in the Ian5 (GIMAP5) gene is the direct cause of T cell lymphopenia in BB rats; transgenic rescue with a wild-type 150-kb PAC transgene fully restored Ian5 transcript, protein, and T cell numbers in lymphopenic F344.lyp/lyp rats. Transgenic rescue with PAC construct in congenic rats; T cell counting; RT-PCR and Western blot for Ian5 expression Physiological genomics High 15328390
2007 GIMAP5 localizes to a sedimentable subcellular fraction distinct from mitochondria and the ER in primary rat T lymphocytes, yet its absence causes rapid loss of mitochondrial membrane potential, indicating GIMAP5 regulates T lymphocyte survival upstream of mitochondria from a distinct compartment. Subcellular fractionation, immunoblotting with GIMAP5 antiserum, confocal microscopy, mitochondrial membrane potential assay (JC-1) in primary rat T cells Biochemical and biophysical research communications Medium 17655828
2008 Selective ablation of mouse Gimap5 impairs final intrathymic maturation of CD8 and CD4 T cells, compromises survival of postthymic T cells, and blocks NK/NKT cell differentiation; NK/NKT developmental defect is cell-extrinsic (restored by transfer of Gimap5-/- bone marrow into wild-type environment), whereas peripheral T cell survival defect and liver pathology are cell-intrinsic. Conditional gene knockout in mice; flow cytometry of thymic and peripheral T cell subsets; bone marrow transfer experiments; Rag2-deficient background crossings Blood High 18796632
2008 Loss of GIMAP5 impairs calcium entry across the plasma membrane (store-operated Ca2+ entry) following thapsigargin or TCR stimulation in rat T lymphocytes, without affecting intracellular Ca2+ store release; the defect manifests in mature single-positive thymocytes. Calcium flux assays (Fura-2) in primary gimap5(lyp/lyp) vs. wild-type rat T cells and thymocytes; thapsigargin and TCR stimulation Molecular immunology Medium 19007993
2009 Absence of GIMAP5 in T cells (but not thymocytes or B cells) causes ER stress, upregulation of ER chaperones, and ER stress-induced apoptotic signaling through CHOP; siRNA-mediated knockdown of CHOP protected GIMAP5-deficient T cells from apoptosis, identifying ER stress/CHOP as a mechanistic pathway downstream of GIMAP5 loss. ER stress marker analysis by Western blot; siRNA knockdown of CHOP; apoptosis assay in Gimap5(-/-) BBDP rat T cells PloS one Medium 19424493
2010 A missense mutation in the P-loop (GTPase domain) of Gimap5 causes loss of lymphocyte quiescence and failure to proliferate upon antigen-receptor stimulation, without affecting NF-κB, MAPK, or Akt activation; the defect operates via a noncanonical signaling pathway. The phenotype is hematopoietic cell-intrinsic as demonstrated by fetal liver chimera reconstitution. ENU germline mutagenesis; fetal liver chimera reconstitution; lymphocyte proliferation assays; signaling pathway analysis (NF-κB, MAPK, Akt) by Western blot Journal of immunology High 20190135
2010 Endogenous GIMAP5 localizes to lysosomes and multivesicular bodies in lymphoid cells (rat, mouse, human Jurkat), as determined by co-localization with lysosomal markers and electron microscopy; by contrast, GIMAP1 localizes to the Golgi. Confocal microscopy with lysosomal markers, subcellular fractionation + immunoblotting, electron microscopy of inducible epitope-tagged Jurkat T cells, novel monoclonal antibodies against GIMAP5 Self/nonself High 21487483
2011 Gimap5 is required for survival of hematopoietic stem and progenitor cells; its absence disrupts the interaction between Mcl-1 and HSC70, enhances Mcl-1 protein degradation, and compromises mitochondrial integrity in progenitor cells. Gimap5 can physically bind to Bcl-2. Gimap5 knockout mice; co-immunoprecipitation of Mcl-1/HSC70; Western blot for Mcl-1 stability; mitochondrial integrity assay; flow cytometry of HSC/progenitor populations The Journal of experimental medicine High 21502331
2011 Loss of Gimap5 in CD4+ T cells is associated with progressive loss of Foxo1, Foxo3, and Foxo4 protein expression, linking Gimap5 to the Foxo transcription factor pathway that maintains immunological tolerance; Gimap5-deficient CD4+ T cells become Th1/Th17 polarized and drive colitis. Gimap5(sph/sph) ENU mouse model; Western blot for Foxo proteins; T cell polarization assays; adoptive transfer experiments Journal of immunology Medium 22106000
2013 GIMAP5 promotes mitochondrial calcium sequestration following capacitative calcium entry in T cells; overexpression of GIMAP5 in HEK-293 cells increases mitochondrial Ca2+ accumulation. Microtubule disruption (but not actin disruption) abrogates mitochondrial Ca2+ sequestration, and GIMAP5 partially co-localizes with tubulin, suggesting GIMAP5 facilitates microtubule-dependent mitochondrial Ca2+ buffering. Ca2+ imaging with mitochondria-targeted aequorin and Fura-2 in primary rat T cells and HEK-293 overexpression; cytoskeleton disruption (nocodazole vs. cytochalasin D); co-localization with tubulin by confocal The Biochemical journal Medium 23098229
2013 Gimap3 and Gimap5 both associate with antiapoptotic Bcl-2 family proteins and cooperate to maintain T cell numbers in mice; double knockout of Gimap3 and Gimap5 causes more severe T cell lymphopenia than Gimap5 deficiency alone. Gimap3/Gimap5 single and double knockout mouse generation; flow cytometry; retroviral overexpression and shRNA silencing of Gimap3 in bone marrow reconstitution European journal of immunology Medium 24510501
2015 Loss of GIMAP5 results in increased basal activation of the PI3K/AKT/mTOR pathway in T lymphocytes, independent of PP2A or AMPK activity. Western blot for phospho-AKT and mTOR substrates in Gimap5-deficient mouse and rat T cells; pharmacological inhibitor studies (PP2A inhibitors, AMPK inhibitors, rapamycin) PloS one Medium 26440416
2015 Quantitative changes in Gimap5 (lysosomal) and Gimap3 (endoplasmic reticulum) expression levels affect mitochondrial DNA segregation in mouse hematopoietic tissues, linking lysosomal and ER membrane protein scaffolds to mtDNA haplotype selection. Allele-specific Gimap3 expression analysis; uORF identification; mtDNA haplotype quantification by PCR in hematopoietic tissues; organelle marker co-localization (confocal) for Gimap3 localization Genetics Medium 25808953
2016 Functional Gimap5 is required for optimal TCR signaling and IL-7 receptor signaling; Gimap5-deficient T cells fail to proliferate in response to cognate antigen and show decreased STAT5 phosphorylation after IL-7 stimulation. OTII TCR-transgenic Gimap5(sph/sph) mice; antigen-stimulation proliferation assay; phospho-STAT5 Western blot/flow cytometry after IL-7 stimulation in rat and mouse Gimap5-deficient T cells PloS one Medium 27023180
2018 GIMAP5 is essential for inactivation of GSK3β following T cell activation; in its absence, constitutive GSK3β activity suppresses c-Myc induction and NFATc1 nuclear import, thereby limiting CD4+ T cell proliferation. GIMAP5 also facilitates Ser389 phosphorylation and nuclear translocation of GSK3β to limit DNA damage. Pharmacological or genetic inhibition of GSK3β rescues Gimap5-deficient CD4+ T cell proliferation and ameliorates immunopathology in mice. A human patient with GIMAP5 LOF mutation shows impaired T cell proliferation rescued by GSK3 inhibitors. Gimap5-deficient mouse model; Western blot and nuclear fractionation for GSK3β phosphorylation/localization; c-Myc and NFATc1 nuclear import assay; GSK3β conditional KO crosses; pharmacological GSK3 inhibition; human patient T cell assay with GSK3 inhibitor rescue Nature communications High 29382851
2021 GIMAP5 is expressed in hepatic sinusoidal endothelial cells (LSECs) and its loss—in humans with homozygous damaging mutations and in mice with endothelial-specific deletion—causes capillarization of LSECs and portal hypertension. Single-cell RNA-seq places GIMAP5 upstream of GATA4, a transcription factor required for LSEC specification. Human genetics (4 families); conditional endothelial-specific Gimap5 KO in mice; single-cell RNA-seq; immunofluorescence for LSEC markers; portal pressure measurement The Journal of experimental medicine High 33956074
2021 GIMAP5 interacts with M6PR (mannose-6-phosphate receptor) and promotes transport of M6PR from cytoplasm to cell membrane, thereby inhibiting PADI4-driven EMT in lung cancer cells. Co-IP combined with mass spectrometry; Western blot; immunofluorescence for M6PR localization; EMT marker analysis in GIMAP5-overexpressing lung cancer cell lines Frontiers in oncology Medium 34604035
2023 GIMAP5 forms a protein complex with MFSD1 (a lysosomal membrane solute carrier) and GLMP (glycosylated lysosomal membrane protein); interactions between MFSD1/GLMP and GIMAP5 are essential for maintaining normal GIMAP5 protein expression levels, which in turn support lymphocyte development and liver homeostasis. Proteomic analysis (mass spectrometry) of MFSD1 interactors; ENU-induced alleles + germline KO of Mfsd1, Glmp, Gimap5; co-immunoprecipitation; Western blot for GIMAP5 protein levels in KO backgrounds Proceedings of the National Academy of Sciences of the United States of America High 38055739
2023 GIMAP5 interacts with M6PR and promotes lysosomal degradation of RSV; GIMAP5 also downregulates the RSV surface receptor IGF1R. GIMAP5 agonist compounds inhibit RSV infection in vitro and in vivo. Co-IP; Western blot; indirect immunofluorescence; transmission electron microscopy of lysosomal RSV degradation in GIMAP5-overexpressing and -silenced cells; in vivo RSV model with GIMAP5 agonists Journal of medical virology Medium 36484389
2024 GIMAP5 restricts pathological accumulation of long-chain ceramides (CERs) by interacting with protein kinase CK2 and attenuating CK2's ability to activate ceramide synthases. Loss of GIMAP5 leads to CER overaccumulation, cell senescence, and early mortality. Inhibition of CK2 or ceramide synthase rescues GIMAP5-deficient T cells from CER overaccumulation and deterioration. Human genetic disease identification; Co-IP of GIMAP5 with CK2; lipidomic quantification of ceramide species; pharmacological inhibition of CK2 and ceramide synthase; T cell survival/senescence assays in GIMAP5-deficient cells Nature immunology High 38172257

Source papers

Stage 0 corpus · 36 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2007 The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus. Journal of medical genetics 68 17220214
2010 Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice. Journal of immunology (Baltimore, Md. : 1950) 56 20190135
2008 Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood 56 18796632
2003 Irod/Ian5: an inhibitor of gamma-radiation- and okadaic acid-induced apoptosis. Molecular biology of the cell 50 12925764
2009 CHOP mediates endoplasmic reticulum stress-induced apoptosis in Gimap5-deficient T cells. PloS one 48 19424493
2007 IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes and immunity 36 17641683
2018 Gimap5-dependent inactivation of GSK3β is required for CD4+ T cell homeostasis and prevention of immune pathology. Nature communications 34 29382851
2004 Transgenic rescue demonstrates involvement of the Ian5 gene in T cell development in the rat. Physiological genomics 33 15328390
2010 The autoimmunity-related GIMAP5 GTPase is a lysosome-associated protein. Self/nonself 32 21487483
2011 Critical role for Gimap5 in the survival of mouse hematopoietic stem and progenitor cells. The Journal of experimental medicine 30 21502331
2007 GIMAP5 regulates mitochondrial integrity from a distinct subcellular compartment. Biochemical and biophysical research communications 28 17655828
2003 Genetic dissection of lymphopenia from autoimmunity by introgression of mutated Ian5 gene onto the F344 rat. Journal of autoimmunity 28 14624755
2006 Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene. Gastroenterology 26 17064701
2021 GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension. The Journal of experimental medicine 25 33956074
2007 Both Gimap5 and the diabetogenic BBDP allele of Gimap5 induce apoptosis in T cells. International immunology 25 17369194
2011 Loss of immunological tolerance in Gimap5-deficient mice is associated with loss of Foxo in CD4+ T cells. Journal of immunology (Baltimore, Md. : 1950) 24 22106000
2013 Gimap3 and Gimap5 cooperate to maintain T-cell numbers in the mouse. European journal of immunology 23 24510501
2013 GTPase of the immune-associated nucleotide-binding protein 5 (GIMAP5) regulates calcium influx in T-lymphocytes by promoting mitochondrial calcium accumulation. The Biochemical journal 19 23098229
2008 Loss of GIMAP5 (GTPase of immunity-associated nucleotide binding protein 5) impairs calcium signaling in rat T lymphocytes. Molecular immunology 18 19007993
2010 Notch protection against apoptosis in T-ALL cells mediated by GIMAP5. Blood cells, molecules & diseases 13 20817506
2009 IAN5 polymorphisms are associated with systemic lupus erythematosus. Lupus 13 19762377
2018 Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4+ T-cell development and allergic airway disease. The Journal of allergy and clinical immunology 12 30616774
2009 Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene. Physiological genomics 12 19351909
2024 GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nature immunology 10 38172257
2021 Gimap5 Inhibits Lung Cancer Growth by Interacting With M6PR. Frontiers in oncology 10 34604035
2009 Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats. Physiological genomics 9 19996157
2004 The antiapoptotic gene Ian4l1 in the rat: genomic organization and promoter characterization. Gene 9 15474297
2023 Essential role of MFSD1-GLMP-GIMAP5 in lymphocyte survival and liver homeostasis. Proceedings of the National Academy of Sciences of the United States of America 8 38055739
2015 Quantitative changes in Gimap3 and Gimap5 expression modify mitochondrial DNA segregation in mice. Genetics 8 25808953
2015 GIMAP5 Deficiency Is Associated with Increased AKT Activity in T Lymphocytes. PloS one 8 26440416
2016 TCR and IL-7 Signaling Are Altered in the Absence of Functional GTPase of the Immune Associated Nucleotide Binding Protein 5 (GIMAP5). PloS one 7 27023180
2015 Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut. Mediators of inflammation 4 25944983
2019 Exploring the expression and preliminary function of chicken Gimap5 gene. PeerJ 3 31579581
2023 Gimap5 promoted RSV degradation through interaction with M6PR. Journal of medical virology 2 36484389
2025 Quantitative temporal analysis of pancreatic islet T lymphocyte and macrophage infiltration heralded by serum IgE in congenic BioBreeding (BB) Gimap5-/- rats at risk for insulitis and acute onset diabetes. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 0 41042382
2020 [Expression and function characterization of Gimap5 gene from different breeds of broilers]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology 0 32147998